What the labs are producing.
An article joins this feed when it matches these terms. Each one is also a search of its own.
How innovation is changing the buildings we work in: adaptable interiors, energy efficiency, healthier workplaces and data-driven design. The buildings where people work are changing as new technologies, materials, and approaches to design become part of everyday construction. Offices are…
Germany's reluctant-yes rate hits 24%, more than double the UK and US, in an 11,000-person survey. Can a consent rate still be read as a real measure of trust? The document's central claim rests on a distinction that consent dashboards do…
Sector intelligence points to the group as a key provider of targeted omics and biomarker analytics solutions for precision medicine-focused projects. Thermo Fisher's push into proteomic biomarker analytics and immuno-oncology diagnostics is only part of the broader story for this…
NPR Health insurers balk at paying for newborns' RSV immunization in the hospital Many infants are leaving the hospital without getting immunized against RSV. Why? Because many insurance companies won't pay for the shots while the newborn is in the…
A longitudinal study of infants in Panama, Peru, and the United States links Klebsiella- and Escherichia-dominated gut communities in the first month of life to reduced rotavirus vaccine seroconversion, shedding, and elevated gut inflammation.
Age, Oxygen Use Predict Severe RSV in Lung Transplant Medscape Older Age, Baseline Oxygen Use Linked to Worse Outcomes in Lung Transplant Recipients With RSV Among hospitalized lung transplant recipients with respiratory syncytial virus (RSV) infection, nearly 60% developed hypoxic respiratory…
Imagine your car develops a serious problem and, instead of taking it to a mechanic, you decide to learn how to fix it yourself, even though that has nothing to do with your profession. Some things are worth doing on…
John Maraganore, co-founder and executive chair of City Therapeutics. City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference (RNAi) therapies headed by a novel anticoagulant drug. The listing was priced at $18, in the middle of…
From the rockets that reach orbit to the technologies inside the cars, phones and infrastructure Americans rely on every day, some of the most consequential innovations begin as solutions to difficult problems. Today, a growing number of those problems are…
Digital pathology systems company Techcyte has released a bundled offering through Fisher Healthcare designed to digitise slide workflow. The digital pathology bundle combines the Techcyte Fusion AP digital pathology platform with high-throughput slide scanners from precision cancer diagnostics company Epredia.